Coffin, the lead researcher on the methamphetamine-addiction study, said that because the GLP-1 drug is designed to satiate, it can take away that need to always be trying to fill a hole inside of you. The theory has already shown initial promise in alcohol-addiction treatment, which is also being researched at UCSF
Date Accessed: 11/25/19
Research from universities like Universit de Louvain reveals that your body already possesses the biological machinery to produce GLP-1 efficiently
Unlike symptomatic treatments (gabapentinoids, duloxetine), ALC promotes actual nerve fiber regeneration and addresses underlying pathophysiology.[17][2] This disease-modifying potential makes it particularly valuable for early intervention
While the FDA declined to discuss the legality of the sale or use of weight loss peptides, in the past the organization has pursued legal action against suppliers
Media reports suggest appointment requests for GLP-1 therapies surged even more after her disclosure than when Oprah Winfrey spoke about using similar medications